BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24796404)

  • 1. Use and reimbursement of off-label drugs in pediatric anesthesia: the Italian experience.
    Salvo I; Landoni G; Mucchetti M; Cabrini L; Pani L
    Paediatr Anaesth; 2014 Jun; 24(6):625-31. PubMed ID: 24796404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Public financing for off-label use of drugs].
    Hammerman A; Lipschitz Y; Pliskin J; Greenberg D
    Harefuah; 2011 Feb; 150(2):163-7, 204. PubMed ID: 22164947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label use of medications in children undergoing sedation and anesthesia.
    Smith MC; Williamson J; Yaster M; Boyd GJ; Heitmiller ES
    Anesth Analg; 2012 Nov; 115(5):1148-54. PubMed ID: 22451593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
    Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness about and views of parents on the off-label drug use in children.
    Bang V; Mallad A; Kannan S; Bavdekar SB; Gogtay NJ; Thatte UM
    Int J Risk Saf Med; 2014; 26(2):61-70. PubMed ID: 24902503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label use reimbursement.
    Cohen J; Wilson A; Faden L
    Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
    Dos Santos L; Heineck I
    Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric off-label drug use in China: risk factors and management strategies.
    Zhang L; Li Y; Liu Y; Zeng L; Hu D; Huang L; Chen M; Lv J; Yang C
    J Evid Based Med; 2013 Feb; 6(1):4-18. PubMed ID: 23557523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Off-label" prescribing of drugs in the ambulatory care of children and adolescents].
    Bücheler R; Meisner C; Kalchthaler B; Mohr H; Schröder H; Mörike K; Schwoerer P; Schwab M; Gleiter CH
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2551-7. PubMed ID: 12457324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-label and off-label use of respiratory drugs in the Italian paediatric population.
    Baiardi P; Ceci A; Felisi M; Cantarutti L; Girotto S; Sturkenboom M; Baraldi E
    Acta Paediatr; 2010 Apr; 99(4):544-9. PubMed ID: 20105140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label prescriptions in Italian hospices: a national survey.
    Toscani F; Di Giulio P; Campi R; Pellerin I; De Luca A; Casale G;
    J Pain Symptom Manage; 2009 Sep; 38(3):365-71. PubMed ID: 19564095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pricing and reimbursement of pharmaceuticals in Italy.
    Folino-Gallo P; Montilla S; Bruzzone M; Martini N
    Eur J Health Econ; 2008 Aug; 9(3):305-10. PubMed ID: 18566845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs.
    Herbrand AK; Schmitt AM; Briel M; Ewald H; Goldkuhle M; Diem S; Hoogkamer A; Joerger M; Moffa G; Novak U; Hemkens LG; Kasenda B
    JAMA Netw Open; 2021 Mar; 4(3):e210380. PubMed ID: 33651108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies.
    Doherty DR; Pascuet E; Ni A; Stewart P; Splinter W; Vaillancourt R
    Can J Anaesth; 2010 Dec; 57(12):1078-88. PubMed ID: 20924803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Off-label drugs use in children--clinical perspective].
    Kwinta P
    Przegl Lek; 2011; 68(1):1-3. PubMed ID: 21563434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.